List of works - Douglas Tremblay

1090. Practicing Antimicrobial Stewardship: De-escalating Empiric Antibiotics in Patients with Acute Myelogenous Leukemia and Neutropenic Fever

A Simple and Powerful Risk-Adjustment Tool for 30-day Mortality Among Inpatients

scientific article published on July 2016

Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19

scientific article published on 20 August 2020

An Opportunity for Hospice Referral in Acute Myeloid Leukemia: Prognostic Significance of Hospitalization Status at Time of Second Cycle of Hypomethylating Agents for Patients Ineligible for Intensive Induction Chemotherapy

scientific article published on 01 November 2020

Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies

scientific article

COVID-19 Pneumonia as a Cause of Acute Chest Syndrome in an Adult Sickle Cell Patient

scientific article published on 03 April 2020

Cell wall localization of Red clover necrotic mosaic virus movement protein is required for cell-to-cell movement

scientific article published in March 2005

Characteristics, anticoagulation, and outcomes of portal vein thrombosis after intra-abdominal surgery

scientific article published on 24 December 2020

Clinical Benefit Derived from Decitabine Therapy for Advanced Phases of Myeloproliferative Neoplasms

scientific article published on 11 March 2020

Comment on "Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis"

scientific article published on 24 September 2020

Comparing the epidemiology, clinical characteristics and prognostic factors of acute myeloid leukemia with and without acute promyelocytic leukemia

scientific article published on 01 July 2019

Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer Patients

scientific article published on 17 September 2020

Differences in the clinical and genetic profile of Hispanic and non-Hispanic acute myeloid leukemia patients

scientific article published on 19 December 2018

Discontinuing Tyrosine Kinase Inhibitor Therapy in Chronic Myelogenous Leukemia: Current Understanding and Future Directions.

scientific article published on 16 June 2016

Ferritin levels in patients with COVID-19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis

scientific article published on 13 August 2020

Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study

scientific article published on 27 May 2020

Implications of Mutation Profiling in Myeloid Malignancies-PART 1: Myelodysplastic Syndromes and Acute Myeloid Leukemia

scientific article published on 15 April 2018

Ironing out the details of iron overload in myelofibrosis: Lessons from myelodysplastic syndromes

scientific article published on 19 April 2016

Management of bone health in postmenopausal women on aromatase inhibitors (AIs): a single health care system experience

scientific article published on 26 July 2017

Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms

scientific article published on 12 November 2019

Modern management of splenomegaly in patients with myelofibrosis

scientific article published on 17 May 2020

Myoclonic jerks complicating treatment of acute promyelocytic leukemia: case report and literature review

scientific article published on 01 June 2019

Novel Therapies in Polycythemia Vera

scientific article published on 07 February 2020

Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience

scientific article published on 16 October 2019

Pacritinib demonstrates spleen volume reduction in patients with myelofibrosis independent of JAK2V617F allele burden

scientific article published on 01 December 2020

Pacritinib to treat myelofibrosis patients with thrombocytopenia

scientific article published on 19 July 2018

Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis

scientific article published on 27 February 2020

Pharmacotherapy of Myelofibrosis

scientific article

Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis

scientific article published on 22 January 2019

Portal vein thrombosis patients harboring JAK2V617F have poor long-term outcomes despite anticoagulation

scientific article published on 07 February 2020

Practicing Antimicrobial Stewardship: De-Escalating Antibiotics in Patients With Acute Myeloid Leukemia and Neutropenic Fever

scientific article published on 21 April 2020

Predictors of early hemorrhage in acute promyelocytic leukemia

scientific article published on 08 March 2019

Prevalence of Cytopenia in the General Population-A National Health and Nutrition Examination Survey Analysis

scientific article published on 20 November 2020

Programmed cell death-1 pathway inhibition in myeloid malignancies: implications for myeloproliferative neoplasms

scientific article published on 6 January 2017

Protective Role of BTK Inhibitors in Patients with Chronic Lymphocytic Leukemia and COVID-19

scientific article published on 20 May 2020

Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera

scientific article published on 29 May 2020

Reassessing the Safety Concerns of Utilizing Blood Donations from Patients with Hemochromatosis.

scientific article published on 13 September 2017

Reevaluating the role of ferritin in the diagnosis of adult secondary hemophagocytic lymphohistiocytosis

scientific article published on 11 February 2020

Risk factors for infections and secondary malignancies in patients with a myeloproliferative neoplasm treated with ruxolitinib: a dual-center, propensity score-matched analysis

scientific article published on 12 November 2019

SAT-091 Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms.

scientific article published on 30 April 2019

Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Thrombosis

scientific article published on 05 November 2020

Soluble Interleukin-2 Receptor (sIL-2r) Level is a Limited Test for the Diagnosis of Adult Secondary Hemophagocytic Lymphohistiocytosis (HLH)

scientific article published on 30 April 2020

Systematic review and meta-analysis evaluating clinical outcomes in adult acute myeloid leukemia patients with central nervous system involvement

scientific article published in 2024

Systemic Mastocytosis: Clinical Update and Future Directions.

scientific article published on 05 August 2015

The Gender Revolution

article

The Implications of Liver Biopsy Results in Patients with Myeloproliferative Neoplasms Being Treated with Ruxolitinib